RTX Healthcare Launches Wireless Telehealth Monitor with built-in GSM/GPRS Mobile Phone Technology

RTX Healthcare today announced a new member to the family of interactive telehealth monitors, which allows healthcare system integrators and disease management companies to effectively monitor patients at home. The RTX3371 GSM/GPRS Telehealth Monitor collects vital signs wirelessly from external devices and subjective patient information from patient questionnaires and transmits the data directly to the system integrator or disease management company's own clinical information system. The collected vital signs include weight, blood pressure, blood glucose, peak flow, SpO2, ECG, blood coagulation and others. All external devices are products from major third party medical device manufacturers.

Bjarne Flou, CEO of RTX Healthcare says, "Expanding our product portfolio to include a GSM/GPRS mobile phone technology enabled Telehealth Monitor is a natural next step in the progression of our vision to become the preferred supplier of telehealth equipment. Our Telehealth Monitors are extremely simple and intuitive to use for elderly patients. Furthermore, the flexibility of the device and our business model, where RTX Healthcare sell the RTX3371 Telehealth Monitor for a one-off fee without a proprietary backend, makes our monitors an easy and preferred choice for telehealth providers." Bjarne Flou continues, "The RTX3371 GSM/GPRS Telehealth Monitor is the second member of a family of telehealth monitors, which also include the RTX3370 monitor with built-in PSTN landline phone modem."

About RTX Healthcare A/S
RTX Healthcare focuses entirely on helping people suffering from chronic diseases to live a better and longer life with their disease. RTX Healthcare specializes in the development and manufacturing of wireless medical devices for remote monitoring. It is RTX Healthcare's vision to be known and recognized as a market leader in the healthcare industry at delivering the most appropriate and cost-effective telehealth solutions. RTX Healthcare is a subsidiary company of RTX Telecom A/S, which is based in Denmark with offices in California and Hong Kong. RTX Telecom A/S is listed on the Nordic Stock Exchange, Copenhagen (OMX). For further information, please visit: www.rtx.dk.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...